• 14 Oct 19

  Proposed Share Consolidation

• 14 Oct 19

  Notice of Annual General Meeting/Proxy Form

• 04 Oct 19

  ArTiMist Appeal Reasons for Decision

• 02 Oct 19

  Response to ASX Query regarding Accounts

• 01 Oct 19

  TGA Declines ArTiMist Appeal

• 30 Sep 19

  Dr Boreham’s Crucible: Suda Pharmaceuticals

• 30 Sep 19

  Insight into Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceutical’s FY19 Annual Report

• 24 Sep 19

  Appendix 4G and Corporate Governance Statement

• 24 Sep 19

  Annual Report to shareholders

• 24 Sep 19

  Final Director’s Interest Notice (Appendix 3Z)